[1]
Lee J,Yi S,Kang YE,Kim HW,Joung KH,Sul HJ,Kim KS,Shong M, Morphological and Functional Changes in the Thyroid Follicles of the Aged Murine and Humans. Journal of pathology and translational medicine. 2016 Nov;
[PubMed PMID: 27737529]
[2]
Liu Y,Su L,Xiao H, Review of Factors Related to the Thyroid Cancer Epidemic. International journal of endocrinology. 2017;
[PubMed PMID: 28555155]
[3]
Parameswaran R,Shulin Hu J,Min En N,Tan WB,Yuan NK, Patterns of metastasis in follicular thyroid carcinoma and the difference between early and delayed presentation. Annals of the Royal College of Surgeons of England. 2017 Feb;
[PubMed PMID: 27659362]
[4]
Wallner LP,Banerjee M,Reyes-Gastelum D,Hamilton AS,Ward KC,Lubitz C,Hawley ST,Haymart MR, Multilevel Factors Associated With More Intensive Use of Radioactive Iodine for Low-Risk Thyroid Cancer. The Journal of clinical endocrinology and metabolism. 2021 May 13
[PubMed PMID: 33687063]
[5]
Eberhardt NL,Grebe SK,McIver B,Reddi HV, The role of the PAX8/PPARgamma fusion oncogene in the pathogenesis of follicular thyroid cancer. Molecular and cellular endocrinology. 2010 May 28
[PubMed PMID: 19883731]
[6]
Marotta V,Bifulco M,Vitale M, Significance of RAS Mutations in Thyroid Benign Nodules and Non-Medullary Thyroid Cancer. Cancers. 2021 Jul 27;
[PubMed PMID: 34359686]
[7]
McHenry CR,Phitayakorn R, Follicular adenoma and carcinoma of the thyroid gland. The oncologist. 2011;
[PubMed PMID: 21482585]
[9]
Furukawa K,Preston D,Funamoto S,Yonehara S,Ito M,Tokuoka S,Sugiyama H,Soda M,Ozasa K,Mabuchi K, Long-term trend of thyroid cancer risk among Japanese atomic-bomb survivors: 60 years after exposure. International journal of cancer. 2013 Mar 1;
[PubMed PMID: 22847218]
[10]
Aceves C,Mendieta I,Anguiano B,Delgado-González E, Molecular Iodine Has Extrathyroidal Effects as an Antioxidant, Differentiator, and Immunomodulator. International journal of molecular sciences. 2021 Jan 27
[PubMed PMID: 33513754]
[11]
Knobel M,Medeiros-Neto G, Relevance of iodine intake as a reputed predisposing factor for thyroid cancer. Arquivos brasileiros de endocrinologia e metabologia. 2007 Jul;
[PubMed PMID: 17891233]
[12]
FORTNER JG,GEORGE PA,STERNBERG SS, Induced and spontaneous thyroid cancer in the Syrian (golden) hamster. Endocrinology. 1960 Mar;
[PubMed PMID: 13855794]
[13]
Avgerinos KI,Spyrou N,Mantzoros CS,Dalamaga M, Obesity and cancer risk: Emerging biological mechanisms and perspectives. Metabolism: clinical and experimental. 2019 Mar;
[PubMed PMID: 30445141]
Level 3 (low-level) evidence
[14]
Choi WJ,Kim J, Dietary factors and the risk of thyroid cancer: a review. Clinical nutrition research. 2014 Jul;
[PubMed PMID: 25136535]
[15]
Aschebrook-Kilfoy B,Ward MH,Della Valle CT,Friesen MC, Occupation and thyroid cancer. Occupational and environmental medicine. 2014 May;
[PubMed PMID: 24604144]
[16]
Nguyen QT,Lee EJ,Huang MG,Park YI,Khullar A,Plodkowski RA, Diagnosis and treatment of patients with thyroid cancer. American health
[PubMed PMID: 25964831]
[17]
Roman BR,Morris LG,Davies L, The thyroid cancer epidemic, 2017 perspective. Current opinion in endocrinology, diabetes, and obesity. 2017 Oct;
[PubMed PMID: 28692457]
Level 3 (low-level) evidence
[18]
Lo CY,Chan WF,Lam KY,Wan KY, Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival. Annals of surgery. 2005 Nov;
[PubMed PMID: 16244545]
[19]
Kitahara CM,Sosa JA,Shiels MS, Influence of Nomenclature Changes on Trends in Papillary Thyroid Cancer Incidence in the United States, 2000 to 2017. The Journal of clinical endocrinology and metabolism. 2020 Dec 1;
[PubMed PMID: 32984898]
[20]
King AD, Imaging for staging and management of thyroid cancer. Cancer imaging : the official publication of the International Cancer Imaging Society. 2008 Mar 25;
[PubMed PMID: 18390389]
[21]
Cipriani NA,Nagar S,Kaplan SP,White MG,Antic T,Sadow PM,Aschebrook-Kilfoy B,Angelos P,Kaplan EL,Grogan RH, Follicular Thyroid Carcinoma: How Have Histologic Diagnoses Changed in the Last Half-Century and What Are the Prognostic Implications? Thyroid : official journal of the American Thyroid Association. 2015 Nov;
[PubMed PMID: 26440366]
[22]
Zanella AB,Scheffel RS,Weinert L,Dora JM,Maia AL, New insights into the management of differentiated thyroid carcinoma in children and adolescents (Review). International journal of oncology. 2021 May
[PubMed PMID: 33649842]
[23]
McHenry CR,Sandoval BA, Management of follicular and Hürthle cell neoplasms of the thyroid gland. Surgical oncology clinics of North America. 1998 Oct;
[PubMed PMID: 9735140]
[24]
Yu F,Li X,Ji Y,Tan J,Zhang G,Wang P,He Y,Wang R, Delayed Initial Radioiodine Adjuvant Therapy Does Affect Biochemical Response in Intermediate- to High-Risk Differentiated Thyroid Cancer. Frontiers in endocrinology. 2021
[PubMed PMID: 34858329]
[25]
Loh KC,Greenspan FS,Gee L,Miller TR,Yeo PP, Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. The Journal of clinical endocrinology and metabolism. 1997 Nov;
[PubMed PMID: 9360506]
Level 2 (mid-level) evidence
[26]
Forrer F,Fischer G,Maas O,Giovanella L,Hoffmann M,Iakovou I,Luster M,Mihailovic J,Petranovic Ovčaričekj P,Vrachimis A,Zerdoud S,Putora PM, Variations in Radioiodine Therapy in Europe - Decision-Making after Total Thyroidectomy. Oncology. 2021 Nov 17
[PubMed PMID: 34788758]
[27]
Raue F,Frank-Raue K, Thyroid Cancer: Risk-Stratified Management and Individualized Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016 Oct 15;
[PubMed PMID: 27742787]
[28]
Xu G,Chen J,Wang G,Xiao J,Zhang N,Chen Y,Yu H,Wang G,Zhao Y, Resveratrol Inhibits the Tumorigenesis of Follicular Thyroid Cancer via ST6GAL2-Regulated Activation of the Hippo Signaling Pathway. Molecular therapy oncolytics. 2020 Mar 27;
[PubMed PMID: 32055676]
[29]
Chen DW,Rob FI,Mukherjee R,Giordano TJ,Haymart MR,Banerjee M, Variation in the Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features. The Journal of clinical endocrinology and metabolism. 2022 Sep 28;
[PubMed PMID: 35918064]
[30]
Borowczyk M,Woliński K,Więckowska B,Jodłowska-Siewert E,Szczepanek-Parulska E,Verburg FA,Ruchała M, Sonographic Features Differentiating Follicular Thyroid Cancer from Follicular Adenoma-A Meta-Analysis. Cancers. 2021 Feb 24;
[PubMed PMID: 33668130]
Level 1 (high-level) evidence
[31]
Ruanpeng D,Cheungpasitporn W,Thongprayoon C,Hennessey JV,Shrestha RT, Systematic Review and Meta-analysis of the Impact of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on Cytological Diagnosis and Thyroid Cancer Prevalence. Endocrine pathology. 2019 Sep;
[PubMed PMID: 31338752]
Level 1 (high-level) evidence
[32]
Beg S,Khan SI,Cui I,Scognamiglio T,Rao R, Analysis of a pre-2017 follicular variant papillary thyroid carcinoma cohort reclassified as noninvasive follicular thyroid neoplasm with papillary-like features (NIFTP): a 11-year retrospective single institution experience. Journal of the American Society of Cytopathology. 2022 Sep 29;
[PubMed PMID: 36372672]
Level 2 (mid-level) evidence
[33]
Mainthia R,Wachtel H,Chen Y,Mort E,Parangi S,Sadow PM,Lubitz CC, Evaluating the projected surgical impact of reclassifying noninvasive encapsulated follicular variant of papillary thyroid cancer as noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Surgery. 2018 Jan;
[PubMed PMID: 29146229]
[34]
Xu D,Wang Y,Wu H,Lu W,Chang W,Yao J,Yan M,Peng C,Yang C,Wang L,Xu L, An artificial intelligence ultrasound system's ability to distinguish benign from malignant follicular-patterned lesions. Frontiers in endocrinology. 2022;
[PubMed PMID: 36387869]
[35]
Yang GCH,Fried KO, Pathologic basis of the sonographic differences between thyroid cancer and noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Ultrasonography (Seoul, Korea). 2018 Apr;
[PubMed PMID: 29137452]
[36]
Bauer AJ, Papillary and Follicular Thyroid Cancer in children and adolescents: Current approach and future directions. Seminars in pediatric surgery. 2020 Jun;
[PubMed PMID: 32571505]
Level 3 (low-level) evidence
[37]
Thompson LD,Wieneke JA,Paal E,Frommelt RA,Adair CF,Heffess CS, A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer. 2001 Feb 1;
[PubMed PMID: 11169933]
[38]
Asban A,Chung SK,Xie R,Lindeman BM,Balentine CJ,Kirklin JK,Chen H, Gender and Racial Disparities in Survival After Surgery Among Papillary and Patients With Follicular Thyroid Cancer: A 45-Year Experience. Clinical medicine insights. Endocrinology and diabetes. 2019;
[PubMed PMID: 31598065]
[39]
Su DH,Chang TC,Chang SH, Prognostic factors on outcomes of follicular thyroid cancer. Journal of the Formosan Medical Association = Taiwan yi zhi. 2019 Jul;
[PubMed PMID: 30541677]
[40]
Hassan A,Khalid M,Riaz S,Nawaz MK,Bashir H, Follicular Thyroid Carcinoma: Disease Response Evaluation Using American Thyroid Association Risk Assessment Guidelines. European thyroid journal. 2015 Dec;
[PubMed PMID: 26835430]
[41]
Gillanders SL,O'Neill JP, Prognostic markers in well differentiated papillary and follicular thyroid cancer (WDTC). European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2018 Mar;
[PubMed PMID: 28801060]
[42]
Mihailovic J,Stefanovic L,Malesevic M, Differentiated thyroid carcinoma with distant metastases: probability of survival and its predicting factors. Cancer biotherapy
[PubMed PMID: 17600472]
[43]
D'Avanzo A,Treseler P,Ituarte PH,Wong M,Streja L,Greenspan FS,Siperstein AE,Duh QY,Clark OH, Follicular thyroid carcinoma: histology and prognosis. Cancer. 2004 Mar 15;
[PubMed PMID: 15022277]
[45]
Rahib L,Smith BD,Aizenberg R,Rosenzweig AB,Fleshman JM,Matrisian LM, Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer research. 2014 Jun 1
[PubMed PMID: 24840647]